| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 6.636 | 38.680 | 35.863 | 46.322 | 40.110 |
| Total Income - EUR | - | - | - | - | - | 6.636 | 38.680 | 35.863 | 46.322 | 40.110 |
| Total Expenses - EUR | - | - | - | - | - | 36 | 3.046 | 14.390 | 20.016 | 16.603 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 6.600 | 35.634 | 21.474 | 26.306 | 23.507 |
| Net Profit/Loss - EUR | - | - | - | - | - | 6.401 | 34.627 | 20.858 | 25.915 | 22.328 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bamamed Ati S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 159 | 485 | 270 | 54 | 686 |
| Current Assets | - | - | - | - | - | 6.482 | 34.353 | 25.201 | 26.770 | 23.478 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 2.109 | 1.031 | 24.262 | 18.562 | 19.996 |
| Cash | - | - | - | - | - | 4.374 | 33.322 | 938 | 8.208 | 3.482 |
| Shareholders Funds | - | - | - | - | - | 6.442 | 34.680 | 20.907 | 25.964 | 22.376 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 199 | 158 | 4.564 | 860 | 1.787 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bamamed Ati S.r.l.